Dear all,

I am approaching EBV culturing, both clinical isolates and laboratory strains.

I found different options for laboratory strains on ATCC (e.g., Strain HR1 (clone of P3) or Strain B95-8). Which one do you think is easier to be produced? Is it possible to amplify it in the correspondent cell line directly or is it better to induce the replication of the latent virus by appropriate stimuli (e.g. TPA)?

About clinical isolates...is it possible to obtain a productive infection (w/o immortalization) to get a virus stock? Which cell line is more appropriate?

Thanks in advance

More Valentina Dell'Oste's questions See All
Similar questions and discussions